Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

NCT05490264 is registered in ClinicalTrials.gov with SmartNuclide Biopharma as lead sponsor.

NCT NCT05490264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05490264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
Lead sponsor
SmartNuclide Biopharma
Phase
Phase 1
Overall status
Unknown status
Start date
October 18, 2022
Completion date
July 30, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

positron-emission tomography(pet), solid tumor